Developing a vaccine for pandemic coronaviruses
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
This study is working on a new vaccine to help protect people from coronaviruses that could cause future outbreaks, so we can be better prepared and keep everyone safe from serious illnesses.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11250793 on NIH RePORTER |
What this research studies
This research focuses on creating a vaccine to protect against coronaviruses that could cause future pandemics. It involves formulating and manufacturing vaccine components, conducting stability tests, and evaluating the vaccine's effectiveness and safety through animal models. The ultimate goal is to prepare for potential outbreaks by ensuring that the vaccine is ready for clinical trials and can be safely administered to humans. Patients may benefit from this research as it aims to provide a preventive measure against severe infectious diseases.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals at high risk for severe coronavirus infections, such as those with underlying health conditions.
Not a fit: Patients who are not at risk for coronavirus infections or those who have already been vaccinated against current strains may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to a vaccine that significantly reduces the risk of severe illness from future coronavirus outbreaks.
How similar studies have performed: Other research has shown success in developing vaccines for coronaviruses, particularly with the rapid development of COVID-19 vaccines, indicating that this approach has potential.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Saunders, Kevin — Duke University
- Study coordinator: Saunders, Kevin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.